Wuyi International Pharmaceutical Co Ltd ($1889) - buy or sell? Stock discussion, ideas, forum

Wuyi International Pharmaceutical Co Ltd

Wuyi International Pharmaceutical Company Limited is a pharmaceutical group.

Industry: Pharmaceuticals

Ticker	Exchange	ISIN	Name
$1889	HKEx Main Board	KYG980891082	Code: 1889

Recent news

TAI Ping Carpet International Ltd revenue jumped on 34.8% while EBITDA Margin decreased on 2.8 pp from 9.9% to 7.1%

Vision Fame International Holding Ltd revenue growth accelerated from 2.3% in FY2019 to 405% in FY2020

Kantone Holdings Ltd reports 13.0% EBITDA growth in 2020 and 0.61 pp EBITDA Margin growth from 5.7% to 6.3%

Heng Tai Consumables Group Ltd revenue dropped on 35.5% and EBITDA Margin dropped on 19.0 pp from -27.6% to -46.6%

Yat Sing Holdings Ltd revenue decreased on 8.4% and EBITDA Margin decreased on 2.2 pp from -1.7% to -3.9%

Art Textile Technology International Co Ltd Net Debt / EBITDA surged on 82.8x from 3.9x to 86.8x in 2020 while Revenue dropped on 24.7%

China Zenith Chemical Group Ltd revenue dropped on 39.8% while EBITDA Margin surged on 93.4 pp from -149% to -55.4%

Odella Leather Holdings Ltd revenue returned to growth in FY2020: increased 60.4% vs. 48.6% decline a year earliner

New World Development Co Ltd Net Income dropped on 85.3% and Revenue dropped on 23.1%

NWS Holdings Ltd reports 80.3% Net Income decline in 2020 and 3.4% Revenue decline

Twit about 1889 stock

Share your investment idea or question on Wuyi International Pharmaceutical Co Ltd stock:

Latest twits on Wuyi International Pharmaceutical Co Ltd (1889)

No twits yet. Be the first to post!

Have a question about 1889? Ask and other investors will be eager to help you.

Have an idea about 1889? Share it with other investors.

Wuyi International Pharmaceutical Co Ltd news

06/04/2016 Wuyi International Pharmaceutical Co Ltd reports 194% Net Income growth and 1.1% Revenue growth

Wuyi International Pharmaceutical Co Ltd stock price chart

Wuyi International Pharmaceutical Co Ltd financials

mln. CNY	FY2010	FY2011	FY2012

Revenue	564.5	569.3	528.1
EBITDA	153.2	117.0	81.904
Net income	106.0	56.870	-44.556
CAPEX	12.167	130.5	144.4
Debt	0.005	0.000	0.000
Cash	1,099	815.8	725.1

Wuyi International Pharmaceutical Co Ltd news

06/04/2016 Wuyi International Pharmaceutical Co Ltd reports 194% Net Income growth and 1.1% Revenue growth

About Wuyi International Pharmaceutical Co Ltd

Wuyi International Pharmaceutical Company Limited is a pharmaceutical group. The Group manufactures, markets, and sells branded prescription and over-the-counter western pharmaceuticals and modern Chinese medicines, including injectables.